UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1876
Anavex Life Sciences
AVXL
$137M
| $1.44M | ﹤0.01% |
162,053
-65,688
| -29% | -$666K |
2025 Q1
2 quarters
|
|
1877
Sweetgreen
SG
$1.26B
| $1.44M | ﹤0.01% |
179,933
-128,368
| -42% | -$1.4M |
2021 Q4
15 quarters
|
|
1878
Magnera Corp
MAGN
$401M
| $1.43M | ﹤0.01% |
121,634
-25,393
| -17% | -$315K |
2024 Q4
3 quarters
|
|
1879
Endeavour Silver
EXK
$2.46B
| $1.42M | ﹤0.01% |
180,823
-15,143
| -8% | -$89.4K |
2024 Q2
5 quarters
|
|
1880
XPEL
XPEL
$1.22B
| $1.42M | ﹤0.01% |
42,836
-32,180
| -43% | -$1.14M |
2021 Q2
17 quarters
|
|
1881
DELISTED
Cantaloupe
CTLP
| $1.41M | ﹤0.01% |
133,096
-32,024
| -19% | -$349K |
2023 Q3
8 quarters
|
|
1882
Sabre
SABR
$722M
| $1.4M | ﹤0.01% |
767,421
-451,795
| -37% | -$1.07M |
2014 Q2
45 quarters
|
|
1883
NPK International
NPKI
$906M
| $1.4M | ﹤0.01% |
124,141
-113,088
| -48% | -$1.1M |
2023 Q4
7 quarters
|
|
1884
Weis Markets
WMK
$1.87B
| $1.4M | ﹤0.01% |
19,435
-25,513
| -57% | -$1.86M |
2019 Q2
25 quarters
|
|
1885
Ameresco
AMRC
$1.07B
| $1.39M | ﹤0.01% |
41,469
-49,652
| -54% | -$1.14M |
2023 Q1
10 quarters
|
|
1886
Canadian National Railway
CNI
$72.9B
| $1.39M | ﹤0.01% |
14,746
-991,451
| -99% | -$95.7M |
2024 Q2
5 quarters
|
|
1887
Grindr
GRND
$2.62B
| $1.38M | ﹤0.01% |
92,151
-66,551
| -42% | -$1.17M |
2024 Q4
3 quarters
|
|
1888
PRA Group
PRAA
$751M
| $1.38M | ﹤0.01% |
89,581
-62,957
| -41% | -$1.02M |
2013 Q2
49 quarters
|
|
1889
Definium Therapeutics
DFTX
$4.6B
| $1.38M | ﹤0.01% |
117,239
+75,110
| +178% | +$700K |
2024 Q2
5 quarters
|
|
|
OS
1890
DELISTED
OneStream Inc
OS
| $1.38M | ﹤0.01% |
74,815
-85,274
| -53% | -$1.87M |
2024 Q4
3 quarters
|
|
1891
IDT Corp
IDT
$2.04B
| $1.38M | ﹤0.01% |
26,323
-26,864
| -51% | -$1.67M |
2023 Q4
7 quarters
|
|
1892
Tronox
TROX
$565M
| $1.37M | ﹤0.01% |
341,862
-177,931
| -34% | -$814K |
2013 Q2
49 quarters
|
|
1893
Byline Bancorp
BY
$1.67B
| $1.37M | ﹤0.01% |
49,528
-41,361
| -46% | -$1.15M |
2021 Q2
17 quarters
|
|
1894
Nuvation Bio
NUVB
$1.67B
| $1.37M | ﹤0.01% |
370,861
-318,994
| -46% | -$869K |
2024 Q2
5 quarters
|
|
1895
Cracker Barrel
CBRL
$1.51B
| $1.37M | ﹤0.01% |
31,073
-23,841
| -43% | -$1.38M |
2013 Q2
49 quarters
|
|
1896
CorMedix
CRMD
$581M
| $1.36M | ﹤0.01% |
116,824
-73,018
| -38% | -$883K |
2025 Q1
2 quarters
|
|
1897
KKR Real Estate Finance Trust
KREF
$350M
| $1.36M | ﹤0.01% |
150,754
+89,046
| +144% | +$828K |
2018 Q4
27 quarters
|
|
1898
Vestis
VSTS
$1.9B
| $1.35M | ﹤0.01% |
297,779
-102,826
| -26% | -$527K |
2023 Q4
7 quarters
|
|
1899
Sprout Social
SPT
$701M
| $1.35M | ﹤0.01% |
104,392
-80,507
| -44% | -$1.31M |
2020 Q3
20 quarters
|
|
1900
Ezcorp Inc
EZPW
$2.04B
| $1.35M | ﹤0.01% |
70,826
-57,044
| -45% | -$894K |
2022 Q4
11 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.